Advancements in Molecular Imaging Driving Expansion of the US Diagnostic Radiopharmaceutical Industry
The United States Diagnostic Radiopharmaceutical is experiencing steady growth, driven by the increasing adoption of advanced nuclear medicine technologies and the growing demand for early and accurate disease diagnosis. The country has a well-established healthcare infrastructure, widespread availability of PET and SPECT imaging systems, and significant investments in precision medicine....
0 Comments 0 Shares 24 Views 0 Reviews